Gainers
- Immix Biopharma, Inc. (NASDAQ:IMMX) rose 42.2% to $2.63 in pre-market trading after declining around 14% on Wednesday. Immix Biopharma, last month, announced positive interim data from an animal study in Soft Tissue Sarcoma (STS).
- Missfresh Limited (NASDAQ:MF) rose 27.3% to $0.3118 in pre-market trading after gaining over 51% on Wednesday.
- Chewy, Inc. (NYSE:CHWY) rose 17.5% to $27.60 in pre-market trading after the company reported better-than-expected Q1 sales results.
- Repare Therapeutics Inc. (NASDAQ:RPTX) rose 17.1% to $10.25 in pre-market trading. Repare Therapeutics entered into a collaboration and license agreement with Hoffmann-La Roche and F. Hoffmann-la Roche.
- Selecta Biosciences, Inc. (NASDAQ:SELB) shares rose 15.2% to $0.97 in pre-market trading after declining around 5% on Wednesday.
- Blue Apron Holdings, Inc. (NYSE:APRN) rose 13.3% to $3.48 in pre-market trading after the company announced it will be offering a selection of meal kits without a subscription on Walmart.com.
- Revelation Biosciences, Inc. (NASDAQ:REVB) rose 12.2% to $0.4944 in pre-market trading after dipping 16% on Wednesday.
- UiPath Inc. (NYSE:PATH) shares rose 11% to $18.68 in pre-market trading after the company reported better-than-expected Q1 EPS and sales results. The company also issued Q3 and FY23 sales guidance above analysts’ estimates.
- Burning Rock Biotech Limited (NASDAQ:BNR) rose 10.2% to $2.60 in pre-market trading. Burning Rock received CE Mark for its OverC Multi-Cancer Detection Blood Test Kit.
- Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) rose 9.4% to $1.98 in pre-market trading after declining around 6% on Wednesday.
- BioXcel Therapeutics, Inc. (NASDAQ:BTAI) rose 8.3% to $11.71 in pre-market trading after declining around 8% on Wednesday.
- Evofem Biosciences, Inc. (NASDAQ:EVFM) rose 8.2% to $0.3749 in pre-market trading. Evofem Biosciences, last month, announced pricing of a roughly $26.6 million public offering.
- MongoDB, Inc. (NASDAQ:MDB) rose 8% to $261.11 in pre-market trading after the company reported Q1 EPS results up from last year and better-than-expected sales results. The company also issued Q2 sales guidance above analysts’ estimates.
- Redbox Entertainment Inc. (NASDAQ:RDBX) rose 7.2% to $6.02 in pre-market trading after declining over 16% on Wednesday.
